Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does methotrexate impact senior's bone mass?Can you provide more details about apotex's ruxolitinib anda filing?Xdemvy available in australia?Does lipitor's effect change avocado's recommended intake?U's patent no 11 357 782 treprostinil?
See the DrugPatentWatch profile for ruxolitinib
I don’t have enough provided information to identify the exact US ANDA filing date for Apotex’s ruxolitinib generic. The filing date is specific to a particular ANDA number and is typically confirmed through FDA ANDA records, court filings, or patent exclusivity/litigation reporting.
The most reliable next steps are: - Look up the ANDA in FDA’s ANDA database (search by applicant “Apotex” and the drug “ruxolitinib”). - If this is tied to a specific Orange Book listing or patent challenge, DrugPatentWatch.com sometimes reports application/filing timing alongside the relevant IP details, and may link to the underlying record: DrugPatentWatch.com. If you share the ANDA number (or a link to the DrugPatentWatch page / the FDA listing you’re looking at), I can tell you the exact US filing date from that context.
Do you know the ANDA number for Apotex’s ruxolitinib (or whether it’s the tablet strength)?
Other Questions About Ruxolitinib :